Standalone ResultsIn Cr.

Particulars Qtr Ending Qtr Ending

Mar 15 Mar 14 Var. (%)

Sales 7675.63 7094.10 8

OPM (%) 17.20 15.20

OP 1318.18 1077.55 22

Other Income 98.41 150.63 -35

PBIDT 1416.59 1228.18 15

Interest (Income)/expenses 0.00 5.33 -100

PBDT 1416.59 1222.85 16

Depreciation 70.52 65.77 7

PBT before EO 1346.07 1157.08 16

Exceptional Items 179.40 66.03 172

PBT after EO 1525.47 1223.11 25

Total Tax 507.39 350.98 45

Net profit 1018.08 872.13 17

EPS 4.71 4.03

May 14, 2015Hindustan Unilever Limited

Current Price:

Price (`) 843.05

52 W H/L(`) 979.00/554.55

Mkt. Cap.(` Cr) 182390.91

Latest Equity(Subscribed) 216.35

Latest Reserve 3507.76

Latest EPS-Unit Curr. 17.80

Latest P/E Ratio 47.36

Latest Bookvalue -Unit Curr. 17.21

Latest P/BV 48.99

Dividend Yield -% 1.54

Face Value 1.00

VALUE PARAMETERS

`843.05

STOCK DATA

BSE Code 500696

NSE Symbol HINDUNILVR

Reuters HLL.BO

Bloomberg HUVR IN

Hindustan Unilever (HUL) matched street estimates with the fourth quarter profit

rising 16.7 percent year-on-year to `1,018 crore compared to `872 crore in the

year-ago period.

The net sales have increased by 8% to ̀ 7675.63 crore. The Domestic Consumer business grew

at 9%, with 6% underlying volume growth, both ahead of market.

In Soaps and Detergents, growth sustained. Skin Cleansing delivered volume-led growth driven

by Lifebuoy, Liril and Pears. The liquids portfolio registered another strong quarter led by

Lifebuoy Handwash. In Laundry, growth was led by the premium segment with Surf

maintaining its volume led double digit growth momentum and Rin delivering good growth on

the bars portfolio. Comfort Fabric Conditioners continued to do well. Vim led the performance in

Household Care. The quarter witnessed price deflation across these categories, as the benefit

of lower commodity costs was passed on to consumers.

Personal Products growth steps up across all categories. Skin Care delivered double digit

growth driven by Fair and Lovely and Pond's. Fair and Lovely continued to perform well while

Pond's growth was led by premium skin lightening and talc.

Hair Care sustained its strong volume led growth momentum with broad based double digit

growth. Dove led the category performance while Clinic Plus, Sunsilk and TRESemmé continued

to make very good progress.

In Oral Care, Close Up registered double digit growth on the back of impactful activation.

Pepsodent growth was driven by Gum Care and Clove & Salt variants.

Colour Cosmetics delivered innovation led double digit growth with Lakme continuing to

strengthen its position in premium make up, driven by a range of exciting and contemporary

offerings from Absolute and 9 to 5.

Beverages had strong growth in Tea and Coffee. Tea delivered double digit growth led by Taj

Mahal, Red Label and 3 Roses. Lipton Green Tea registered another quarter of high growth on

sustained market development. In Coffee, the performance was driven by Bru Gold, which

continued to lead category premiumization.

1

SHARE HOLDING PATTERN (%)

Description as on % of Holding

31/03/2015

Foreign 15.37

Institutions 3.82

Non Promoter Corp. Hold. 1.13

Promoters 67.23

Public & Others 12.45

®

2

Standalone Segmented ResultsIn Cr.

Particulars Qtr Ending Qtr Ending Var %

Mar 15 Mar 14 (%) of total

Soaps & Detergents 3673.71 3497.12 5 48

Personal Products 2249.68 1983.29 13 29

Beverages 976.15 869.04 12 13

Packaged Foods 476.83 419.68 14 6

Others 294.70 295.79 0 4

Total 7671.07 7064.92 9 100

Segment Results (PBIT)

Soaps & Detergents 488.25 421.71 16 37

Personal Products 624.52 495.81 26 48

Beverages 181.61 163.04 11 14

Packaged Foods 25.40 22.96 11 2

Others -7.83 -25.05 -69 -1

TOTAL 1311.95 1078.47 22 100

Packaged Foods had sixth successive quarter of double digit growth. Market development

continues to be the focus, resulting in double digit growth across all key brands. Kissan

sustained its strong activation-led growth momentum while Knorr registered volume led

growth as Instant Soups more than doubled sales and new Chinese flavours were added to the

Noodles portfolio. Ice Creams delivered another strong quarter, led by Magnum and sharper in-

market execution on Kwality Walls. A new variant, Magnum Choco Cappuccino was introduced

during the season.

Pureit growth was led by the premium segment with Ultima (RO+UV) continuing to deliver

strongly. The quarter saw the launch of a new Marvella (RO+UV) device.

Input costs were benign and this is reflected in the reduction in cost of goods sold. Investment

behind brands was sustained at competitive levels. The margin for the quarter includes a one-

time credit of Rs 71.5 crore towards a favourable outcome for a contested matter on Excise

Duty.

As a result, OPM inclined by 198 bps to 17.2%. There was fall in raw material cost by 220 bps to

38.08%, purchase of traded goods by 128 bps to 11.88%, employee cost by 20 bps to 5.05%

and other cost by 30 bps to 14.49% of adjusted net sales. However, there was rise

advertisement & promotion (ASP) cost by 170 bps to 13.36% of adjusted net sales. The

operating profit inclined by 22% to ̀ 1318.18 crore.

Other income has decreased by 35% to ̀ 98.41 crore, which includes interest income, dividend

income and net gain on sale of other non-trade current investments. Depreciation inclined by

7% to ̀ 70.52 crore. Profit before tax and exceptional item inclined by 16% to Rs 1346.07 crore.

There was an exceptional income of ̀ 179.40 crore, growth of 172%. Exceptional items includes

profit on sale of surplus properties ̀ 70.7 crore, profit on sale of wholly owned subsidiary Brooke

Bond Real Estate Pvt Ltd ̀ 168.97 crore, reduction in provision for retirement benefit arising out

of change in actuarial assumption of `5.37 crore and restructuring cost of `2.02 crore. The

profit before tax and after exceptional items has inclined by 25% to ̀ 1525.47 crore.

Tax outgo has increased by 45% to `507.39 crore. The effective tax rate was increased from

28.69% to 33.26%. The net profit has increased by 17% to Rs 1018.08 crore due to increase in

OPM and EO income.

®

3

®

Segmented results

Soaps & detergents: At standalone level, the revenue has increased by 5% to ̀ 3673.71 crore

for Q4 FY15. PBIT margins had inclined by 120 bps to 13.3%. As a result, PBIT had increased by

16% to `488.25 crore. The category contributed around 48% to the revenues while the

contribution to PBIT stood at 37%.

Personal care: At standalone level, the revenues grew 13% to `2249.68 crore for Q4 FY15.

PBIT margin have increased by 280 bps to 27.8%. As a result, the PBIT has increased by 26% to

`624.52 crore. The category contributed around 29% to the revenues while the contribution to

PBIT stood 48%.

Beverages: At standalone level, the sales grew by 12% to `976.15 crore for Q4 FY15. The

segment contributed 13% to the total revenues. PBIT margin has declined by 20 bps to 18.6%.

As a result, PBIT has inclined by 11% to ̀ 181.61 crore. It contributes 14% to the total PBIT.

Packaged Foods: At standalone level, the sales have increased by 14% to ̀ 476.83 crore for

Q4 FY15. The segment contributed 6% to the total revenues. PBIT margin declined by 14 bps to

5.3%.The PBIT has increased by11% to Rs 25.40 crore.

Other Business

At standalone level, the sales stood at ̀ 294.70 crore for Q4 FY15. The segment contributed 4%

to the total revenues. The loss at PBIT level decreased by 69% to ̀ 7.83 crore.

Other Developments

The Board of Directors has proposed a final dividend of ̀ 9 per share, subject to the approval of

the shareholders at the AGM. Together with the interim dividend of `6 per share, the total

dividend for the financial year ending 31st March, 2015 amounts to ̀ 15 per share.

Management Comments

Harish Manwani, Chairman commented: We have delivered another year of strong

performance with broad based growth ahead of the market and sustained margin

improvement. Our strategy remains focused on strengthening the core of our business through

innovation, leading market development and continuous improvement of our executional

capabilities. Despite market challenges, our strategic agenda remains unchanged as we

continue to manage our business even more dynamically for growth that is consistent,

competitive, profitable and responsible.

4

®

SMC Global Securities Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, a further public offering of its equity shares and has filed the Draft Red Herring Prospectus with the Securities and Exchange Board of India (“SEBI”) and the Stock Exchanges. The Draft Red Herring Prospectus is available on the website of SEBI at www.sebi.gov.in and on the websites of the Book Running Lead Manager i.e., ICICI Securities Limited at www.icicisecurities.com and the Co- Book Running Lead Manager i.e., Elara Capital (India) Private Limited at www.elaracapital.com . Investors should note that investment in equity shares involves a high degree of risk and for details relating to the same, please see the section titled “Risk Factors” of the aforementioned offer document.

Disclaimer: This report is for the personal information of the authorized recipient and doesn't construe to be any investment, legal or taxation advice to you. It is only for private circulation and use .The report is based upon information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon as such. No action is solicited on the basis of the contents of the report. The report should not be reproduced or redistributed to any other person(s)in any form without prior written permission of the SMC. The contents of this material are general and are neither comprehensive nor inclusive. Neither SMC nor any of its affiliates, associates, representatives, directors or employees shall be responsible for any loss or damage that may arise to any person due to any action taken on the basis of this report. It does not constitute personal recommendations or take into account the particular investment objectives, financial situations or needs of an individual client or a corporate/s or any entity/s. All investments involve risk and past performance doesn't guarantee future results. The value of, and income from investments may vary because of the changes in the macro and micro factors given at a certain period of time. The person should use his/her own judgment while taking investment decisions. Please note that we and our affiliates, officers, directors, and employees, including persons involved in the preparation or issuance if this material;(a) from time to time, may have long or short positions in, and buy or sell the securities thereof, of company (ies) mentioned here in or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company (ies) discussed herein or may perform or seek to perform investment banking services for such company(ies) or act as advisor or lender/borrower to such company(ies) or (c) may have any other potential conflict of interest with respect to any recommendation and related information and opinions. All disputes shall be subject to the exclusive jurisdiction of Delhi High court.

Corporate Office:

11/6B, Shanti Chamber,

Pusa Road, New Delhi - 110005

Tel: +91-11-30111000

www.smcindiaonline.com

Mumbai Office:

Dheeraj Sagar, 1st Floor,

Opp. Goregaon sports club, link road

Malad (West), Mumbai - 400064

Tel: 91-22-67341600, Fax: 91-22-28805606

Kolkata Office:

18, Rabindra Sarani,

"Poddar Court", Gate No. 4,

4th Floor, Kolkata - 700001

Tel: 91-33-39847000, Fax: 91-33-39847004

E-mail: researchfeedback@smcindiaonline.com

®

SMC Research also available on Reuters

SMC Global Securities Ltd. (hereinafter referred to as “SMC”) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and its associate is member of MCX stock

Exchange Limited. It is also registered as a Depository Participant with CDSL and NSDL. Its associates merchant banker and Portfolio Manager are registered with SEBI and NBFC registered with RBI. It also has

registration with AMFI as a Mutual Fund Distributor.

SMC is in the process of making an application with SEBI for registering as a Research Entity in terms of SEBI (Research Analyst) Regulations, 2014. SMC or its associates has not been debarred/ suspended by

SEBI or any other regulatory authority for accessing /dealing in securities Market.

SMC or its associates including its relatives/analyst do not hold any financial interest/beneficial ownership of more than 1% in the company covered by Analyst. SMC or its associates and relatives does not have any

material conflict of interest. SMC or its associates/analyst has not received any compensation from the company covered by Analyst during the past twelve months. The subject company has not been a client of SMC

during the past twelve months. SMC or its associates has not received any compensation or other benefits from the company covered by analyst or third party in connection with the research report. The Analyst has

not served as an officer, director or employee of company covered by Analyst and SMC has not been engaged in market making activity of the company covered by Analyst.

The views expressed are based solely on information available publicly available/internal data/ other reliable sources believed to be true.

SMC does not represent/ provide any warranty express or implied to the accuracy, contents or views expressed herein and investors are advised to independently evaluate the market conditions/risks involved before

making any investment decision.

SMC Research Desk